Authors: Kosmidis, P Mylonakis, N Skarlos, D Samantas, E Dimopoulos, M Papadimitriou, C Kalophonos, C Pavlidis, N Nikolaidis, C Papaconstantinou, C Fountzilas, G

Citation: P. Kosmidis et al., Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial, ANN ONCOL, 11(7), 2000, pp. 799-805

Authors: Kosmidis, P Mylonakis, N Dimopoulos, A Pavlidis, N Fountzilas, G Samantas, E Dimitriadis, K Kalophonos, C Tsavdaridis, D Skarlos, D

Citation: P. Kosmidis et al., Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results, SEMIN ONCOL, 27(1), 2000, pp. 3-8